Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

× No keyword cloud information.

13 in total

1. CIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma.

Authors: Jian Y Cheng; Ratnavelu Kananathan
Journal: Hum Vaccin Immunother Date: 2012-08-21 Impact factor: 3.452

2. Effects of a clinical pathway of pulmonary lobectomy and bilobectomy on quality and cost of care.

Authors: Matthias Schwarzbach; Eric Rössner; Torsten Schattenberg; Stefan Post; Peter Hohenberger; Ulrich Ronellenfitsch
Journal: Langenbecks Arch Surg Date: 2010-02-21 Impact factor: 3.445

3. Neoplastic pericardial disease: Old and current strategies for diagnosis and management.

Authors: Chiara Lestuzzi
Journal: World J Cardiol Date: 2010-09-26

4. Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population.

Authors: Xiaohong Han; Zhishang Zhang; Di Wu; Yinchen Shen; Shuai Wang; Lin Wang; Yutao Liu; Sheng Yang; Xingsheng Hu; Yun Feng; Yan Sun; Yuankai Shi
Journal: Transl Oncol Date: 2014-12 Impact factor: 4.243

5. The similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patients.

Authors: Hye-Ryoun Kim; Min Soo Kang; Im Il Na; Sung Hyeon Yang; Yoon Hee Choi; Hye Jin Kang; Cheol Hyeon Kim; Jae Cheol Lee
Journal: J Cancer Res Clin Oncol Date: 2009-09-30 Impact factor: 4.553

6. SEOM guidelines for the management of non-small-cell lung cancer (NSCLC).

Authors: E Felip; P Garrido; J M Trigo; M López-Brea; L Paz-Ares; M Provencio; D Isla
Journal: Clin Transl Oncol Date: 2009-05 Impact factor: 3.405

Review 7. Gefitinib: a review of its use in the treatment of locally advanced/metastatic non-small cell lung cancer.

Authors: Mark Sanford; Lesley J Scott
Journal: Drugs Date: 2009-11-12 Impact factor: 9.546

Review 8. Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.

Authors: Nicholas Thatcher; Jim Heighway
Journal: Oncologist Date: 2010-10-07

9. Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer.

Authors: Alain Vergnenègre; Joshua A Ray; Christos Chouaid; Francesco Grossi; Helge G Bischoff; David F Heigener; Stefan Walzer
Journal: Clinicoecon Outcomes Res Date: 2012-01-26

10. Malignant pericardial effusion: sclerotherapy or local chemotherapy?

Authors: C Lestuzzi; C Lafaras; A Bearz; R Gralec; E Viel; A Buonadonna; T Bischiniotis
Journal: Br J Cancer Date: 2009-06-09 Impact factor: 7.640